| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 09/30/1999 | CA2324494A1 Apo-2 ligand-anti-her-2 antibody synergism |
| 09/29/1999 | EP0945454A1 Iminochlorinaspartic acid derivatives |
| 09/28/1999 | US5958408 Glycosylation of lysin residue of a clearing agent which is an antibody or an antigen binding fragment of an antibody with a galactose residue for achieving fast clearance |
| 09/28/1999 | US5957960 Internal two photon excitation device for delivery of PDT to diffuse abnormal cells |
| 09/23/1999 | WO1999047162A1 Products in the treatment of cancer |
| 09/23/1999 | CA2324337A1 Products in the treatment of cancer |
| 09/21/1999 | US5955603 Porphyrins and porphyrin synthesis techniques |
| 09/21/1999 | US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives |
| 09/21/1999 | US5955584 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 09/21/1999 | US5955490 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| 09/21/1999 | US5955256 Mixing with photosensitizer and blocking agent of cysteine, n-acetylcysteine, dithiothreitol, butylated hydroxytoluene, butylated hydroxyanisole, tyrosine, histidine, tryptophan, propyl gallate, or mercaptopropionyl glycine |
| 09/21/1999 | US5954703 Method and apparatus for applying 5-aminolevulinic acid |
| 09/16/1999 | WO1999046351A1 Metal nanoshells |
| 09/14/1999 | US5952366 Alkyl ether analogs of chlorins having an N-substituted imide ring |
| 09/14/1999 | US5952311 Photosensitizing chemical means for killing tumor cells, wherein tumoricidal activity is activated by absorbing light or energy within a specific wavelength range, and energy donating chemical means for activating photosensitizer |
| 09/10/1999 | WO1999044638A1 Photothermal structure for biomedical applications, and method therefor |
| 09/10/1999 | WO1999044637A1 Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 09/10/1999 | WO1999044508A1 Integrated poration, harvesting and analysis device, and method therefor |
| 09/10/1999 | WO1999044507A1 Integrated tissue poration, fluid harvesting and analysis device, and method therefor |
| 09/10/1999 | CA2637760A1 Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 09/10/1999 | CA2323160A1 Photothermal structure for biomedical applications, and method therefor |
| 09/08/1999 | EP0939832A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
| 09/08/1999 | EP0621880B1 Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light |
| 09/07/1999 | US5948624 Methods for the detection and isolation of biomolecules |
| 09/07/1999 | US5947956 Laser apparatus for making holes and etchings |
| 09/07/1999 | US5947921 Chemical and physical enhancers and ultrasound for transdermal drug delivery |
| 09/01/1999 | EP0938341A2 Compositions and methods for altering the biodistribution of biological agents |
| 09/01/1999 | CN1227498A 医用粉末 Medical powder |
| 08/31/1999 | US5945439 Method for destroying or inhibiting growth of unwanted cells or tissues |
| 08/27/1999 | CA2230836A1 Inducing resistance to ischemic stresses |
| 08/24/1999 | US5942534 Administering to the patient a photoactivatable compound selected form hematoporphyrins, benzophorphyrins, aminolevulinic acid to treat osteorthritis |
| 08/24/1999 | CA2075895C Compositions containing green porphyrins to destroy malignant cells in mononuclear cell populations |
| 08/19/1999 | WO1999040848A1 Interstitial fluid collection and monitoring device |
| 08/18/1999 | EP0935462A1 Photopheresis treatment of leukocytes |
| 08/18/1999 | EP0935415A1 Methods for delivering compounds into a cell |
| 08/18/1999 | CN1226338A Method of improving skin condition |
| 08/18/1999 | CN1226148A Method for improving selectivity in photo-activation of molecular agents |
| 08/18/1999 | CN1226147A Method for inproving selectivity in photo-activation and detection of molecular diagnosis agents |
| 08/12/1999 | WO1999039765A2 Soft x-ray emitting medical devices |
| 08/12/1999 | WO1999039738A1 Targeted delivery of biologically active media |
| 08/12/1999 | WO1999039720A1 Compositions and methods for modulating cytokine release in response to genotoxic agents |
| 08/12/1999 | WO1999039697A1 Method for ultrasound triggered drug delivery |
| 08/12/1999 | WO1999039647A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs |
| 08/12/1999 | CA2320300A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs |
| 08/12/1999 | CA2319567A1 Compositions and methods for modulating cytokine release in response to genotoxic agents |
| 08/12/1999 | CA2319029A1 Soft x-ray emitting medical devices |
| 08/11/1999 | EP0478545B1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 08/11/1999 | CN1225591A Membrane incorporation of texaphyrins |
| 08/10/1999 | US5935944 Formulation for I.V. administration of the boron delivery drug, boronophenylalanine (BPA) |
| 08/10/1999 | US5935942 Co-administering a fluorescent dye encapsulated within a heat-sensitive liposome and tissue reactive agent activated by irradiation, selectively heating, monitoring, activating by irradiating |
| 08/10/1999 | US5935581 Inhibitory effects of synthetic and natural colorants on carcinogenesis |
| 08/10/1999 | US5935553 Methods of preparing gas-filled liposomes |
| 08/05/1999 | WO1999038870A1 Compounds containing boron for electron microscopy and for boron neutron-capture therapy |
| 08/05/1999 | WO1999038380A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness |
| 08/05/1999 | WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 08/04/1999 | EP0933332A1 Electrolysis of water resulting in the reduction of fat content in the human liver |
| 07/27/1999 | US5929105 Ethylene glycol esters as photoactive agents |
| 07/27/1999 | US5928958 Superparamagnetic particles, process for their manufacture and usage |
| 07/15/1999 | WO1999034858A1 Assessment and control of acoustic tissue effects |
| 07/15/1999 | WO1999034831A1 Enhanced transport using membrane disruptive agents |
| 07/14/1999 | EP0928611A1 Medical powder |
| 07/14/1999 | EP0648205B1 Peptidyl derivatives as metalloproteinase inhibitors |
| 07/14/1999 | CN1222850A Therapeutic treatment for VEGF related occular diseases |
| 07/13/1999 | US5922858 Misaminoacylated transfer ribonucleic acid with photocleavable marker; for incorporation of non-radioactive labels into nascent proteins by cellular or cell-free translation systems |
| 07/13/1999 | US5922304 Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents |
| 07/06/1999 | US5919923 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
| 07/06/1999 | US5919922 Fluorescent dyes free of aggregation and serum binding |
| 07/01/1999 | WO1999032114A1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
| 06/30/1999 | EP0925308A2 Compositions and methods for treating infections using analogues of indolicidin |
| 06/29/1999 | US5916539 Superparamagnetic particles, process for producing the same and their use |
| 06/24/1999 | WO1999030745A2 Dota-biotin derivatives |
| 06/24/1999 | WO1999030713A1 Integrin receptor antagonists |
| 06/24/1999 | CA2315232A1 Integrin receptor antagonists |
| 06/23/1999 | EP0923383A1 Novel dispersible lipid blends and uses therefor |
| 06/22/1999 | US5914345 Treatment with stimulus to induce altered levels of stress response or hear shock proteins |
| 06/22/1999 | US5913884 Inhibition of fibrosis by photodynamic therapy |
| 06/17/1999 | WO1999029302A1 Drug delivery system with two-step targeting |
| 06/17/1999 | DE19803206C1 New tetrakis-carboranylmethyl-propane derivatives useful in boron neutron capture tumor therapy or as labeling agents in energy filtering transmission electron microscopy |
| 06/16/1999 | EP0757690A4 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 06/15/1999 | US5912257 Two-photon upconverting dyes and applications |
| 06/15/1999 | US5912241 Antiprotozoa agents |
| 06/09/1999 | EP0920623A1 Boron neutron capture therapy using pre-targeting methods |
| 06/08/1999 | US5910510 Administering a photoactive absorber, e.g. a porphyrin, and waiting to have it localize in ocular tissue; radiating with laser light; macular degeneration; treating neovascularization |
| 06/03/1999 | WO1999026535A1 Reagent for tumor therapy and/or imaging |
| 06/03/1999 | WO1999026532A1 Electro-medical apparatus |
| 06/03/1999 | CA2310841A1 Reagent for tumor therapy and/or imaging |
| 06/03/1999 | CA2278723A1 Electro-medical apparatus |
| 06/02/1999 | EP0918519A1 Therapeutic treatment for vegf related occular diseases |
| 06/02/1999 | EP0918511A2 Lipid-binding proteins and their therapeutic and diagnostic use |
| 06/02/1999 | EP0918504A2 Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
| 06/02/1999 | CN1218415A Targeted hysteresis hyperthermia as method for treating diseased tissue |
| 06/01/1999 | US5908742 Synthetic media for blood components |
| 05/27/1999 | WO1999025385A1 A method of increasing nucleic acid synthesis with ultrasound |
| 05/27/1999 | WO1999003976A3 Method of treating leukocytes, leukocyte compositions and methods of use thereof |
| 05/25/1999 | US5906977 Conjugate for treating inflammatory diseases |
| 05/25/1999 | US5906824 Substrate; irradiating biopolymer; tackiness to cells but not blood platelets |
| 05/20/1999 | WO1999023882A1 Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| 05/20/1999 | CA2310590A1 Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| 05/19/1999 | EP0915698A1 Therapeutic treatment for vegf related diseases |
| 05/19/1999 | EP0756477A4 Methods for phototherapeutic treatment of proliferative skin diseases |